Test Code OPATM Opiate Confirmation, Meconium
Additional Codes
Mayo Test ID | COPIA Test Code | EPIC Test Codes | |
---|---|---|---|
OPATM | OPATM-Opiate Confirmation, Meconium | LAB0293806 | OPIATE, CONFIRMATION, MECONIUM |
Reporting Name
Opiate Confirmation, MUseful For
Detecting maternal prenatal opiate/opioid use up to 5 months before birth
Method Name
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
MeconiumOrdering Guidance
For chain-of-custody testing, order OPTMX / Opiate Confirmation, Chain of Custody, Meconium.
Specimen Required
Supplies: Stool container, Small (Random), 4 oz (T288)
Container/Tube: Stool container
Specimen Volume: 1 g (approximately 1 teaspoon)
Collection Instructions: Collect entire random meconium specimen.
Specimen Minimum Volume
0.3 g (approximately 1/4 teaspoon)
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Meconium | Frozen (preferred) | 28 days | |
Refrigerated | 28 days | ||
Ambient | 14 days |
Reject Due To
Grossly bloody | Reject; Pink OK |
Stool Diapers |
Reject |
Reference Values
Negative
Positives are reported with a quantitative liquid chromatography tandem mass spectrometry (LC-MS/MS) result.
Cutoff concentrations for LC-MS/MS testing:
Codeine: 20 ng/g
Hydrocodone: 20 ng/g
Hydromorphone: 20 ng/g
Morphine: 20 ng/g
Oxycodone: 20 ng/g
Oxymorphone: 20 ng/g
Day(s) Performed
Monday through Sunday
CPT Code Information
80361
80365
G0480 (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
OPATM | Opiate Confirmation, M | 69026-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
31848 | Morphine | 69027-1 |
31850 | Oxymorphone | 69028-9 |
31849 | Hydromorphone | 68541-2 |
31847 | Codeine | 68542-0 |
31852 | Oxycodone | 68543-8 |
31851 | Hydrocodone | 68544-6 |
31868 | Interpretation | 8215-6 |
31869 | Chain of Custody | 77202-0 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Report Available
2 to 3 daysForms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.